Solara Active makes and active progress on charts.

Solara Active Pharma is a pure API play in the pharma sector. They offer a full spectrum of contract development and manufacturing solutions to clients worldwide powered by its Research & Development (R&D) Centre.

The negative aspects of the company are promoters deceasing stake Q onQ and high pledging. Positive aspect of the company is increase in net profit Q on Q and stock rising after making a bottom.

Entry can be taken after closing above 384. Targets in the stock will be 397 and 414. Long term target will be 428 and 440. Stop loss in the stock should be maintained at Closing below 317.


The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.